DoseSpot
DoseSpot is a Boston-based, cloud-based ePrescribing platform offering certified EPCS, real-time prescription benefit, electronic prior authorization, and patient engagement tools to telehealth providers, health systems, EHR/EMR vendors, dental practices, and solo providers across the United States. Since 2026 it operates as Interra Health following a merger with Arrive Health.
- Company typePrivate
- Founded2009
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What DoseSpot does
DoseSpot (legally PRN Software, founded 2009, headquartered in Boston) provides a cloud-based, certified ePrescribing platform that enables healthcare providers to electronically transmit prescriptions—including controlled substances—directly into a nationwide pharmacy routing network. The platform is offered at three integration tiers: Full Integration (250+ API endpoints, fully customizable UI, 3–6 month rollout), Jumpstart (70+ APIs, plug-and-play iFrame embed, ~30 day implementation, adopted by roughly 74% of clients), and the standalone TreatRx product for solo providers without an EHR (24–72 hour setup). The product stack layers a core ePrescribing engine with Real-Time Prescription Benefit (patient-specific out-of-pocket cost and formulary data at point of care), Electronic Prior Authorization (under 4 minute approval decisions through CoverMyMeds), and DoseSpot Connect (SMS-based patient engagement, copay assistance, and pharmacy selection). Acquired modules pVerify (patient eligibility verification across 350+ API clients) and RxLink (medication affordability) extend the platform into revenue cycle and patient-support workflows, and the March 2026 merger with Arrive Health combines the ePrescribing engine with real-time medical and pharmacy benefit data under the new Interra Health entity.
The go-to-market is dual-track: an enterprise field sales motion with “Request a Demo” qualification targeting health systems, EHR/EMR vendors, dental service organizations, telehealth platforms, and digital health companies; paired with an API-first OEM/embedded channel that distributes the platform behind 140+ endpoints into partner products. Customer segments span Telehealth and Digital Health (DialCare, ChatRx, Hims & Hers, Maven), Health Systems (provider access and 340B performance), EHRs/EMRs (Genensys, InPracSys, OpenDental), Provider Groups, and DSOs and dental practices (Henry Schein, Aspen Dental, Smile Brands), with solo providers addressed via TreatRx. Commercial logic is a subscription SaaS model with multi-year enterprise contracts and quote-based pricing; no public tier pricing is disclosed. Strategic ownership moved through PSG’s 2021–2022 growth equity investment, three follow-on acquisitions, and the March 2026 recapitalization by Bain Capital Tech Opportunities as majority owner of Interra Health, with PSG, Providence, and UPMC Enterprises retaining minority positions. The merged entity is described as already profitable with combined revenue projected above $100M in 2026.
DoseSpot firmographics
Firmographics- Name
- DoseSpot
- Legal name
- PRN Software
- Website
- https://dosespot.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- DoseSpot is a Boston-based, cloud-based ePrescribing platform offering certified EPCS, real-time prescription benefit, electronic prior authorization, and patient engagement tools to telehealth providers, health systems, EHR/EMR vendors, dental practices, and solo providers across the United States. Since 2026 it operates as Interra Health following a merger with Arrive Health.
- Ownership category
- akta.pro rank
DoseSpot industry classification
Industry- Product category
- Healthcare E-Prescribing Software
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Physicians (62111)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
- akta.pro secondary industries
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance (HLACAKAJ)
Keywords
Where DoseSpot is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Markets served
DoseSpot business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS ePrescribing Platform Subscription: Subscription-based software-as-a-service model providing ePrescribing capabilities, insurance verification, and patient engagement tools to healthcare providers and organizations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Custom enterprise pricing based on organization size and integration requirements |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
DoseSpot product offering
Product offeringCore offering
DoseSpot provides a cloud-based, certified electronic prescribing (ePrescribing) platform that enables healthcare providers to electronically send prescriptions, including controlled substances (EPCS), directly to pharmacies. The platform is offered through three integration tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play iFrame), and TreatRx (standalone, no EHR required). Additional capabilities include Real-Time Prescription Benefit checks, Electronic Prior Authorization, patient engagement tools, and insurance eligibility verification (via pVerify).
Product overview
DoseSpot is a certified ePrescribing platform offering a modular product architecture centered on Core ePrescribing as the foundational capability. The platform layers patient-facing tools (DoseSpot Connect with Real-Time Prescription Benefit) and workflow automation (Electronic Prior Authorization) on top of the core ePrescribing engine. Integration is offered at three tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play UI), and TreatRx (standalone, no-EHR-required). Following the 2023 acquisitions of TreatRx and pVerify, and the 2024 acquisition of RxLink, DoseSpot merged with Arrive Health in March 2026 to form Interra Health, expanding into real-time medication price transparency and coverage data.
Differentiator
Problem solved
Functional benefit
Brands
- TreatRx: Simple, affordable, and standalone ePrescribing solution for solo providers without an EHR requirement. EPCS-certified to meet federal and state requirements in all 50 states.
- pVerify
- RxLink
Products and services
- Core ePrescribing Foundational cloud-based ePrescribing platform providing prescription routing, controlled substance prescribing (EPCS), drug interaction and allergy alerts, PDMP integration, medication history, and customizable Sig configurations for healthcare providers.
- DoseSpot Connect Patient engagement module enabling prescription price transparency, medication affordability programs, co-pay savings, pharmacy choice, and SMS-based prescription communications between providers and patients.
- Real-Time Prescription Benefit (RTPB) Real-time drug cost visibility and therapeutic alternative suggestions at point of care, integrated into EHR workflows to enable informed prescribing decisions and improve medication adherence.
- Electronic Prior Authorization (ePA) Integrated prior authorization submission, tracking, and decision-making within ePrescribing workflows, connecting to CoverMyMeds and Surescripts for expanded payer coverage.
- Full Integration Fully customizable cloud-based ePrescribing integration with 250+ API calls, custom screen building, and complete workflow ownership; Surescripts and EPCS certified for enterprise deployments.
- Jumpstart Integration Plug-and-play ePrescribing user interface (iFrame/embedded) with 70+ API calls, customizable CSS theming, enabling ePrescribing in as little as 30 days for healthcare organizations.
- TreatRx Standalone ePrescribing platform requiring no EHR/EMR, EPCS-certified for solo providers and small practices, enabling prescribing from any device with real-time prescription benefit and prior authorization capabilities.
- pVerify Insurance eligibility verification and revenue cycle management solution serving 350+ API clients via API, SFTP, and HL7/FHIR for medical, dental, and vision providers, pharmacies, labs, developers, health plans, and RCM/billing providers.
Quantifiable outcome
- 50M+ prescriptions sent annually
- +8 more outcomes
Companies that use DoseSpot
Customer profileNamed customers20 records
Segments6 records
Ideal customer profiles5 records
DoseSpot technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability3 records
Feature9 records
DoseSpot partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Arrive Health (Merger)coreDoseSpot and Arrive Health merged in March 2026 to form Interra Health. The combination unified ePrescribing platform with medical and pharmacy benefits data to advance real-time medication price transparency.
- Amazon PharmacyminorDoseSpot collaborates with Amazon Pharmacy to improve medication availability and price transparency, connecting patients with Amazon's same-day prescription delivery services.
- Lightning StepminorStrategic collaboration with Lightning Step to give behavioral health organizations access to DoseSpot's ePrescribing capabilities.
- RxLink (Acquisition)coreDoseSpot acquired RxLink in 2024. RxLink was founded by JB Powell who joined DoseSpot as Head of Growth, Patient Support. RxLink focused on medication affordability solutions.
- CoverMyMedscoreCoverMyMeds integration enables electronic prior authorization submission and tracking directly within DoseSpot's ePrescribing workflow, reducing approval rejections and simplifying compliance.
- SurescriptscoreSurescripts network certification enables DoseSpot to route electronic prescriptions nationwide and access eligibility, formulary, and medication history data.
- Pharmacy Benefit Managers (PBMs)coreIntegration with Pharmacy Benefit Managers provides real-time visibility into out-of-pocket costs, formulary alternatives, and cost-saving opportunities for Real-Time Prescription Benefit features.
- pVerify (Acquisition)coreDoseSpot acquired pVerify in June 2023 to enhance its API capabilities for patient eligibility verification. pVerify provides insurance verification and revenue cycle management solutions.
- Bravado Health (TreatRx acquisition)coreDoseSpot acquired TreatRx, Bravado Health's ePrescribing platform, to expand its solution offerings for healthcare providers. The acquisition enhanced DoseSpot's capabilities and support for practice efficiency and compliance.
Scale indicators20 records
Recent moves7 records
Expansion highlights6 records
DoseSpot competitors and assessment
Company assessmentDirect peers
- DrFirst: DrFirst is a direct competitor in the ePrescribing space, offering EPCS-certified ePrescribing, medication management, and EHR-integrated prescribing workflows. Both target healthcare providers, EHRs, and digital health platforms with comparable API-first distribution models.
- RxNT: RxNT is an ePrescribing platform offering EPCS-certified ePrescribing, EPCS, and practice management solutions. It targets ambulatory practices and is comparable to DoseSpot's Full Integration and TreatRx standalone offerings.
- NewCrop: NewCrop provides cloud-based ePrescribing, EPCS, and medication management integrated into EHR and HIT systems. It is a direct API-first competitor with comparable EPCS-certified workflow capabilities.
- CoverMyMeds (McKesson): CoverMyMeds is a leading electronic prior authorization platform integrated into DoseSpot's ePA workflow. It is a partner but also a direct competitor in the medication workflow/PA layer of DoseSpot's product, and as part of McKesson it has deep healthcare distribution scale.
Broad incumbents
- Surescripts: Surescripts is the dominant nationwide prescription routing network and also operates adjacent services (benefit, eligibility, prior authorization). While DoseSpot partners with Surescripts, Surescripts also competes in areas like eligibility/benefit and increasingly in decision support, making it both a partner and a partial competitor.
- Veradigm (Allscripts): Veradigm (formerly Allscripts) provides EHR systems with integrated ePrescribing and EPCS. It represents the broad-incumbent threat where an EHR vendor's native ePrescribing reduces the addressable market for best-of-breed solutions like DoseSpot.
- eClinicalWorks: eClinicalWorks is a major ambulatory EHR vendor offering integrated ePrescribing and EPCS as part of its core suite. It is comparable to DoseSpot as a competitor in the ePrescribing layer for provider practices, particularly for ambulatory and specialty practices.
- Epic Systems: Epic is the dominant EHR for large health systems and offers its own integrated ePrescribing module. While DoseSpot's Jumpstart and Full Integration can work alongside Epic, Epic's native capabilities and tight integration limit DoseSpot's expansion into the largest IDN segment.
- Practice Fusion (Veradigm): Practice Fusion, now part of Veradigm, is a cloud-based EHR with integrated ePrescribing targeted at independent practices. It competes with DoseSpot's TreatRx standalone and embedded offerings for the small-practice segment.
Emerging players
- Kareo (Tebra): Tebra (formed via the merger of Kareo and PatientPop) provides cloud-based practice management and EHR with integrated ePrescribing for independent practices. It overlaps with DoseSpot's TreatRx standalone and Jumpstart offerings for the small-practice and ambulatory segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
DoseSpot social profiles
Digital presenceDoseSpot compliance and trust
Trust signalCompliance8 records
DoseSpot financial estimates
Financial estimateRevenue estimate
Valuation estimate
DoseSpot leadership team
Management profileNumber of profiles
Profiles7 records
DoseSpot subsidiaries and ownership
Company hierarchySubsidiaries3 records
DoseSpot funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DoseSpot M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DoseSpot
What does DoseSpot do?
DoseSpot provides a cloud-based, certified electronic prescribing (ePrescribing) platform that enables healthcare providers to electronically send prescriptions, including controlled substances (EPCS), directly to pharmacies. The platform is offered through three integration tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play iFrame), and TreatRx (standalone, no EHR required). Additional capabilities include Real-Time Prescription Benefit checks, Electronic Prior Authorization, patient engagement tools, and insurance eligibility verification (via pVerify).
Is DoseSpot a public or private company?
DoseSpot is a private company. It is classified as private equity controlled and is currently acquired.
When was DoseSpot founded?
DoseSpot was founded in 2009. It employs 51 to 100 people.
Where is DoseSpot based?
DoseSpot is headquartered in Boston, United States, in the North America region.
How does DoseSpot make money?
One revenue line is on record: saaS ePrescribing Platform Subscription.
Who are DoseSpot's main competitors?
Direct peers on record are DrFirst, RxNT, NewCrop and CoverMyMeds (McKesson). Broad incumbents are Surescripts, Veradigm (Allscripts), eClinicalWorks, Epic Systems and Practice Fusion (Veradigm). Kareo (Tebra) is listed as an emerging player.
Does DoseSpot have an API?
Yes. DoseSpot offers 140+ API endpoints for ePrescribing integration, including Full Integration with 250+ API calls and Jumpstart with 70+ API calls. APIs enable sending and retrieving demographics, medications, allergies, and more. The platform provides push notifications for prescription-specific information and actionable items. API v2 is transitioning to Medi-Span Drug Database. Developer documentation is at go.dosespot.com/jumpstart-partnership_overview.
What industry is DoseSpot in?
DoseSpot's product category is Healthcare E-Prescribing Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 524292 and its SIC code is 7372.